Love Chibuzor Ilochonwu

Dr. Love Chibuzor Ilochonwu


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2024 in Medical Sciences Forum
Verified
Conference Paper
Open access
PDF file
CMCosimo Damiano Giorgio Mangino
Cosimo Damiano Giorgio Mangino
CFCorinna Fortunato
Corinna Fortunato
LILove Chibuzor Ilochonwu
Love Chibuzor Ilochonwu
AMAndrea Mazzacchera
Andrea Mazzacchera
DRDavide Mengarelli detto Rinaldini
Davide Mengarelli detto Rinaldini
FFFabio Filippetti
Fabio Filippetti
The World Health Organization has highlighted the substantial impact of viral hepatitis on individuals, healthcare systems, and economies worldwide. This study’s objective is to monitor disease notifications to assess their trends. Data from infectious disease notifications detected in the Marche Region (Italy) were analyzed and entered into the Nuovo Sistema Informativo Sanitario portal between 1 January 2012 and 31 December 2021. In this period, there were 399 confirmed reports, of which 47.9% were for hepatitis A, 26.8% were for hepatitis B, 7% were for hepatitis C, and 18.3% were for hepatitis E; 67.4% of the afflicted individuals were male, and the average age was 43.5 years old. The year with the highest peak was 2017, accounting for 18% of the reports, while the year with the lowest number was 2020, followed by 2021, accounting for 3.8% and 4.5%, respectively. Effective surveillance systems are key to combating the spread of hepatitis and reducing its impact, although they have been affected by the SARS-CoV-2 pandemic, with many cases remaining undetected.

10 April 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
AIAlessio Iacoangeli
Alessio Iacoangeli
LILove Chibuzor Ilochonwu
Love Chibuzor Ilochonwu
GMGiulia Mazzanti
Giulia Mazzanti
GPGabriele Polonara
Gabriele Polonara
LELauredana Ercolani
Lauredana Ercolani
Denis AiudiDenis Aiudi
Denis Aiudi
Background: Spinal arachnoid cyst development (SAC) is a rare and debilitating disease with a non-well defined treatment strategy: a series of 5 patients diagnosed with SAC, submitted to neurosurgical treatment, was retrospectively analyzed. Objectives: SACs represent 1-2% of all spinal neoplasms: they can be extradural, intradural, or intrame-dullary, with intradural arachnoid cysts (IDACs) comprising only 10% of these cases. The rarity of SACs and the lack of consensus on the best treatment strategies represent a care challenge: the aim of this study is to explore the effectiveness and outcomes of the neu-rosurgical management in patients with SACs treated at our Institution. Methods: Adult patients who underwent surgical treatment for SACs between January 2020 and De-cember 2023 were included in the study: clinical onset, imaging, surgical technique, and neurological long-term status were retrospectively analyzed. Results: Five patients (3 males, 2 females; average age 53.4 years) were included. The most common symptoms described were paresthesia, gait disturbances, and back pain. Radiological imaging in-dicated that most cysts were at the thoracic level. Surgical interventions primarily in-volved cyst resection and adhesiolysis. Postoperative outcomes showed overall im-provement or stability in Karnofsky Performance Status (KPS) and American Spinal Injury Association Impairment Scale (AIS) scores in the majority of cases, although complications and recurrences occurred. Conclusions: Surgical resection combined with adhesiolysis may prevent the worsening of neurological impairment and potentially improve pain control and clinical outcomes in patients with SACs. However, careful and tailored management is required due to the high potential of complications and recurrences.

Verified
Journal Article
Open access
PDF file
AIAlessio Iacoangeli
Alessio Iacoangeli
LILove Chibuzor Ilochonwu
Love Chibuzor Ilochonwu
GMGiulia Mazzanti
Giulia Mazzanti
GPGabriele Polonara
Gabriele Polonara
LELauredana Ercolani
Lauredana Ercolani
Denis AiudiDenis Aiudi
Denis Aiudi
Background: Spinal arachnoid cyst development (SAC) is a rare and debilitating disease with a non-well-defined treatment strategy: a series of five patients diagnosed with SAC and submitted to neurosurgical treatment was retrospectively analyzed. Objectives: SACs represent 1–2% of all spinal neoplasms; they can be extradural, intradural, or intramedullary, with intradural arachnoid cysts (IDACs) comprising only 10% of these cases. The rarity of SACs and the lack of consensus on the best treatment strategies represent a care challenge: the aim of this study is to explore the effectiveness and outcomes of the neurosurgical management in patients with SACs treated at our institution. Methods: Adult patients who underwent surgical treatment for SACs between January 2020 and December 2023 were included in the study: clinical onset, imaging, surgical technique, and neurological long-term status were retrospectively analyzed. Results: Five patients (three males, two females; average age 53.4 years) were included. The most common symptoms described were paresthesia, gait disturbances, and back pain. Radiological imaging indicated that most cysts were at the thoracic level. Surgical interventions primarily involved cyst resection and adhesiolysis. Post-operative outcomes showed overall improvement or stability in Karnofsky Performance Status (KPS) and American Spinal Injury Association Impairment Scale (ASIA) scores in the majority of cases, although complications and recurrences occurred. Conclusions: Surgical resection combined with adhesiolysis may prevent the worsening of neurological impairment and potentially improve pain control and clinical outcomes in patients with SACs. However, careful and tailored management is required due to the high potential of complications and recurrences.

10 October 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
CMCosimo Damiano Giorgio Mangino
Cosimo Damiano Giorgio Mangino
CFCorinna Fortunato
Corinna Fortunato
LILove Chibuzor Ilochonwu
Love Chibuzor Ilochonwu
AMAndrea Mazzacchera
Andrea Mazzacchera
DRDavide Mengarelli detto Rinaldini
Davide Mengarelli detto Rinaldini
FFFabio Filippetti
Fabio Filippetti
The World Health Organization has highlighted the substantial impact of viral hepatitis on individuals, healthcare systems, and economies worldwide. This study's objective is to monitor disease notifications to assess their trend. Data were analyzed from infectious disease notifications detected in the Marche Region (Italy) and entered on the Nuovo Sistema Informativo Sanitario portal between 01/01/2012 and 31/12/2021. In this period there were 399 confirmed reports, of which 47,9% were for hepatitis A, 26,8% for B, 7% for C, 18,3% for E; 67.4% were male and the average age was 43.5 years old. The year with the highest peak was 2017, with 18% of reports, while the year with the lowest number was 2020 followed by 2021, with 3.8% and 4.5% respectively. Effective surveillance systems are key to combating the spread of hepatitis and reducing its impact, although they have been affected by the Sars-CoV-2 pandemic, with many cases remaining undetected.